Compounding Pharmacy Market 2025 to 2034
Compounding Pharmacy Market 2025 to 2034
Compounding Pharmacy Market (By Therapeutic Area: Pain Management, Hormone Replacement, Dermal Disorders, Nutritional Supplements, Others; By Route of Administration: Oral, Topical, Parenteral, Others; By Age: Pediatric, Geriatric, Adult, Veterinary; By Compounding Type: Pharmaceutical Dosage Alteration (PDA), Pharmaceutical Ingredient Alteration (PIA), Currently Unavailable Pharmaceutical Manufacturing (CUPM), Others; By Sterility: Sterile, Non-sterile; By Distribution Channel: Compounding Pharmacy, Hospital Pharmacy, Others; By Region: North America, LAMEA, Europe, Asia-Pacific) - Global Industry Analysis, Size, Trends, Leading Companies, Regional Outlook, and Forecast 2025 to 2034
Customisation Request
Revenue, 2025
USD 18.02
Forecast Year, 2035
USD 31.77 Bn
CAGR, 2025 - 2035
6.50%
Report Coverage
Worldwide
.webp){kind=small}
Published By
Deepa Pandey
Reviewed By
Aditi Shivarkar
Reviewed By
Aman Singh
The global compounding pharmacy market, valued at USD 18.02 billion in 2025, is projected to reach USD 31.77 billion by 2034, expanding at a CAGR of 6.5%, driven by rising personalized medications and specialized therapeutic demand.
Compounding Pharmacy Market Size Analysis
Compounding Pharmacy Market Size By Therapeutic Area 2025 to 2034 (USD Billion)
| Therapeutic Area | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|
| Pain Management | 1.20 | 1.30 | 1.37 | 1.47 | 1.56 | 1.65 | 1.77 | 1.88 | 2.01 | 2.12 |
| Hormone Replacement | 2.41 | 2.57 | 2.74 | 2.91 | 3.10 | 3.28 | 3.52 | 3.74 | 3.99 | 4.23 |
| Dermal Disorders | 3.60 | 3.85 | 4.08 | 4.36 | 4.64 | 4.94 | 5.26 | 5.60 | 5.97 | 6.37 |
| Nutritional Supplements | 4.81 | 5.10 | 5.45 | 5.78 | 6.18 | 6.58 | 6.99 | 7.46 | 7.93 | 8.46 |
| Others | 5.99 | 6.38 | 6.80 | 7.25 | 7.71 | 8.23 | 8.75 | 9.32 | 9.92 | 10.58 |
Compounding Pharmacy Market Size By Route of Administration 2025 to 2034 (USD Billion)
| Route of Administration | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|
| Oral | 1.82 | 1.93 | 2.07 | 2.17 | 2.34 | 2.49 | 2.63 | 2.84 | 3.01 | 3.22 |
| Topical | 3.59 | 3.83 | 4.09 | 4.37 | 4.64 | 4.94 | 5.29 | 5.59 | 5.97 | 6.35 |
| Parenteral | 5.40 | 5.77 | 6.12 | 6.52 | 6.93 | 7.39 | 7.88 | 8.41 | 8.92 | 9.52 |
| Others | 7.20 | 7.67 | 8.16 | 8.71 | 9.27 | 9.87 | 10.49 | 11.17 | 11.92 | 12.67 |
Compounding Pharmacy Market Size By Age 2025 to 2034 (USD Billion)
| Age | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|
| Pediatric | 1.82 | 1.93 | 2.05 | 2.20 | 2.35 | 2.47 | 2.66 | 2.80 | 3.02 | 3.21 |
| Geriatric | 3.61 | 3.85 | 4.07 | 4.35 | 4.62 | 4.96 | 5.24 | 5.59 | 5.97 | 6.34 |
| Adult | 5.40 | 5.75 | 6.14 | 6.52 | 6.96 | 7.38 | 7.89 | 8.41 | 8.93 | 9.53 |
| Veterinary | 7.19 | 7.66 | 8.17 | 8.69 | 9.25 | 9.87 | 10.51 | 11.21 | 11.89 | 12.68 |
Compounding Pharmacy Market Size By Compounding Type 2025 to 2034 (USD Billion)
| Compounding Type | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|
| Pharmaceutical Dosage Alteration (PDA) | 1.81 | 1.91 | 2.07 | 2.18 | 2.35 | 2.48 | 2.64 | 2.81 | 3.02 | 3.20 |
| Pharmaceutical Ingredient Alteration (PIA) | 3.60 | 3.84 | 4.08 | 4.36 | 4.64 | 4.92 | 5.25 | 5.61 | 5.98 | 6.36 |
| Currently Unavailable Pharmaceutical Manufacturing (CUPM) | 5.40 | 5.76 | 6.13 | 6.53 | 6.95 | 7.41 | 7.87 | 8.40 | 8.94 | 9.54 |
| Others | 7.20 | 7.67 | 8.16 | 8.70 | 9.24 | 9.88 | 10.53 | 11.19 | 11.88 | 12.67 |
Compounding Pharmacy Market Size By Sterility 2025 to 2034 (USD Billion)
| Sterility | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|
| Sterile | 6.04 | 6.41 | 6.87 | 7.33 | 7.74 | 8.29 | 8.81 | 9.40 | 10.04 | 10.65 |
| Non-sterile | 11.98 | 12.78 | 13.57 | 14.43 | 15.44 | 16.39 | 17.48 | 18.60 | 19.79 | 21.11 |
Compounding Pharmacy Market Size By Distribution Channel 2025 to 2034 (USD Billion)
| Distribution Channel | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|
| Compounding Pharmacy | 3.04 | 3.19 | 3.45 | 3.66 | 3.89 | 4.15 | 4.41 | 4.68 | 5.00 | 5.34 |
| Hospital Pharmacy | 5.99 | 6.41 | 6.78 | 7.25 | 7.76 | 8.21 | 8.74 | 9.34 | 9.94 | 10.59 |
| Others | 9.00 | 9.59 | 10.21 | 10.86 | 11.53 | 12.33 | 13.14 | 13.99 | 14.88 | 15.84 |
Compounding Pharmacy Market Size By Region 2025 to 2034 (USD Billion)
| Region | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|
| North America | 1.82 | 1.94 | 2.04 | 2.21 | 2.31 | 2.46 | 2.66 | 2.83 | 3.00 | 3.22 |
| LAMEA | 3.61 | 3.83 | 4.10 | 4.35 | 4.66 | 4.96 | 5.27 | 5.62 | 5.97 | 6.36 |
| Europe | 5.39 | 5.75 | 6.14 | 6.52 | 6.95 | 7.42 | 7.86 | 8.39 | 8.94 | 9.52 |
| Asia-Pacific | 7.19 | 7.67 | 8.16 | 8.69 | 9.27 | 9.84 | 10.50 | 11.16 | 11.92 | 12.67 |
Compounding Pharmacy Market Size to Hit USD 31.77 Billion by 2034
The global compounding pharmacy market size accounted for USD 18.02 billion in 2025 and is predicted to touch around USD 31.77 billion by 2034 with a growing at a CAGR of 6.50%.
Proceed To Buy
Proceed To CheckoutMake Every Move Strategic. Get Insights, Fully Customized
- On-Demand Metrics & KPIs
- Industry-Specific Dashboards
- Quick Turnaround, No Compromises
Quick Contact
- NA : +1 804 441 9344
- APAC : +91 9356 9282 04
- EU : +44 7782 560 738
- sales@precedenceresearch.com
